Therefore, the exclusion of early deaths due to sepsis, hemorrhage or chemotherapy complication was essentially done to avoid false misleading results about the effect of IDH mutation on disease burden and patient survival, which if included, a lower overall survival would be reflected to IDH mutation. Here, IDH1 is linked to Sepsis.